• Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 4  |  Issue : 4  |  Page : 95-101

Glioma Research in the era of medical big data

1 Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
2 Department of Pathology, The Preston Robert Tisch Brain Tumor Center At Duke, Duke University Medical Center, Durham, NC, USA

Correspondence Address:
Dr. Xuejun Li
Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ctm.ctm_26_18

Rights and Permissions

Glioma is the most common type of malignant tumor of the central nervous system. Studies of the biological mechanism behind its occurrence and development have significant importance in better understanding glioma. In the era of multiomics and big data, glioma research is undergoing a paradigm shift from traditional standardized medical models to precision medicine. Big data in glioma research is in its infancy, and as such, there are exciting opportunities to take advantage of. However, there are also major challenges that must be addressed. This review introduces a series of changes in glioma research brought about by medical big data. It further elaborates on how big data bioinformatic analyzes can contribute to the identification of molecular targets, leading to molecular pathological diagnosis and the promotion of precision medicine of glioma.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded224    
    Comments [Add]    

Recommend this journal